Read + Share
Amedeo Smart
Independent Medical Education
Holt A, Strange JE, Rasmussen PV, Blanche P, et al. Bleeding Risk Following Systemic Fluconazole or Topical Azoles in Patients with Atrial Fibrillation on Apixaban, Rivaroxaban, or Dabigatran. Am J Med 2022;135:595-602.PMID: 34861201
Email
LinkedIn
Facebook
Twitter
Privacy Policy